Kuvaus
European Cell-Based Assays Interest Group-EuCai ryhmän perustaminenProvide state of the art cell based screening platforms that advance basic research and drug discovery towards improved prediction of clinical efficacy and safety. In particular, the interest group offers expertise in the development, characterization and application of advanced cell biological models such as 3D culture, co-cultures, primary cells and stem cells for screening purposes. By combining innovations in biological model development with new enabling technologies, EuCAI aims at providing cell based screening services and high content analysis solutions that offer enhanced scientific rigour, mechanistic understanding and clinical relevance to academic translational centres, SMEs and the pharmaceutical industry.
Mukana perustamassa EuCai järjestöä Dublinissa vuonna 2012
Body affiliation: perustajajäsen
Aikajakso | 18 helmik. 2012 → 19 helmik. 2012 |
---|---|
Pidetty | European Cell-Based Assays Interest Group-EuCai |
Tunnustuksen arvo | Kansainvälinen |
Tähän liittyvä sisältö
-
Tutkimusinfrastruktuurit
-
FIMM High Throughput Biomedicine Unit
Laitteistot/tilat: Keskuspalveluyksikkö